CRGN
CuraGen Corp. (Nasdaq: CRGN)
I’m back in this one with a current avg of 1.28.
Edit 10/26 position closed.
+14.21%
Tags: BIO, CRGN
This entry was posted
on Friday, September 28th, 2007 at 2:06 PM and is filed under Closed Winners.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
So far not a bad day for CRGN. I would like to see 1.37 or better close but 1.35 is ok. I would like to see some news out on this one.
It rocks today :-)
Come on CRGN strong close! HOD please
Not exactly the close I wanted but it works. Looking at a weekly chart it looks decent, ADX rolling over either parks at 13 or they give it a blast. If not always next week.
http://stockcharts.com/h-sc/ui?s=CRGN&p=W&yr=1&mn=3&dy=0&id=p21054885645
Def. didn’t expect this. Will be watching to see if it can hold ummm say 1.41 if not I’ll book gains and watch for re-entry
Well now at 1.38 x 1.39 looks like I got greedy on this one. Someone just dumped it to 1.36 I can’t see selling this low, I believe the upward trend is right there. I’m on the fence right now.
I’m glad I walked away… Seems to be doing OK now.
9/5 to 9/28 off the lows = trendline
Sold 1/2 at 1.40 from 1.28 9.37% not sure whats going on with the blocks as this thing slides down. When in doubt I back off a tad.
What a hair cut!
Something sure didn’t seem right a few days ago
I still have 1/2 of this thing. Had I been around this morning when the news hit I would have exited but down here I’m going to let it age. Company has a lot of cash and has I believe an event in 2 weeks.
I bought more of this at .98 and .99 I’ll post my avg in a few.
Article just published in Journal of medicine says “Conclusion-
Our data demonstrate that belinostat inhibits bladder cancer and supports the clinical evaluation of belinostat for the treatment of patients with superficial bladder cancer.”
CRGN presenting at the International Cancer Conference Monday. This may be the news that comes out and if it is it should get some nice headlines!
http://www.translational-medicine.com/content/5/1/49
Well I’m averaged in at 1.135 I bought back what I sold before it dumped. Hopefully if things go to plan I’ll be out Monday(pop on possible news), if not I’ll see how it goes. Trading action since the drop has been interesting. They walk it down and someone quickly comes in to take it all. One or more funds that recently opened a position last Q are probably averaging down. CRGN is at / near all time lows. They have a lot of cash w/ convertible debt. More times then not when a market rolls over Bio’s usually do OK
Just got in at 0.93. The stock looked cheap considered with low-ish Volume. Where is the news we are waiting for?
“Where is the news we are waiting for?”
You mean this news :)
http://biz.yahoo.com/prnews/071024/new082.html?.v=23
CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
Wednesday October 24, 4:05 pm ET
- Initial clinical trial results suggesting safety and clinical activity of CR011-vcMMAE reported at the AACR-NCI-EORTC International Conference -
You are scaring me :-).
Let’s have a nice pop now.
I have never done it before. I just scalped it before the bell at 0.98.
More news,
http://biz.yahoo.com/prnews/071025/neth094.html?.v=21
CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
Thursday October 25, 4:00 pm ET
- Significant anti-tumor activity of combination IV belinostat in ovarian cancer reported -
- Oral belinostat demonstrated to be safe and well-tolerated in Phase I -
- Presentation of results from two NCI-sponsored clinical trials -
- CuraGen to provide a clinical update conference call today at 5:00 p.m. Eastern Time -
That’s the news I’ve been waiting for….
belinostat
from post 11
Position closed 1.19 +4.84%
That was a nicely controlled recovery on your part. Did I miss anything :-)?
I see I we both left a good percentage on the table